BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33495232)

  • 1. Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis.
    Zhu M; Huang Y; Bender ME; Girard L; Kollipara R; Eglenen-Polat B; Naito Y; Savage TK; Huffman KE; Koyama S; Kumanogoh A; Minna JD; Johnson JE; Akbay EA
    Cancer Res; 2021 Apr; 81(7):1813-1826. PubMed ID: 33495232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer group 2D receptor and its ligands in cancer immune escape.
    Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
    Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.
    Baragaño Raneros A; Martín-Palanco V; Fernandez AF; Rodriguez RM; Fraga MF; Lopez-Larrea C; Suarez-Alvarez B
    Genes Immun; 2015; 16(1):71-82. PubMed ID: 25393931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice.
    Hua L; Fang M; Dong B; Guo S; Cui C; Liu J; Yao Y; Xiao Y; Li X; Ren Y; Meng X; Hao X; Zhao P; Song Y; Wang L; Yu Y
    Oncotarget; 2016 Dec; 7(50):82369-82383. PubMed ID: 27448968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone Deacetylation.
    Zhao P; Sun X; Li H; Liu Y; Cui Y; Tian L; Cheng Y
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10.
    Fang X; Guo L; Xing Z; Shi L; Liang H; Li A; Kuang C; Tao B; Yang Q
    Pharmacol Res; 2022 Mar; 177():106132. PubMed ID: 35183714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
    Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
    Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8
    Lerner EC; Woroniecka KI; D'Anniballe VM; Wilkinson DS; Mohan AA; Lorrey SJ; Waibl-Polania J; Wachsmuth LP; Miggelbrink AM; Jackson JD; Cui X; Raj JA; Tomaszewski WH; Cook SL; Sampson JH; Patel AP; Khasraw M; Gunn MD; Fecci PE
    Nat Cancer; 2023 Sep; 4(9):1258-1272. PubMed ID: 37537301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17.
    Ren J; Nie Y; Lv M; Shen S; Tang R; Xu Y; Hou Y; Zhao S; Wang T
    Cell Mol Immunol; 2015 Nov; 12(6):768-76. PubMed ID: 25363527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.
    Stojanovic A; Correia MP; Cerwenka A
    Front Immunol; 2018; 9():827. PubMed ID: 29740438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruiting T cells and sensitizing tumors to NKG2D immune surveillance for robust antitumor immune response.
    Li X; Guo X; Huang J; Lin Q; Qin B; Jiang M; Shan X; Luo Z; Zhang J; Shi Y; Lu Y; Liu X; Du Y; Yang F; Luo L; You J
    J Control Release; 2023 Jan; 353():943-955. PubMed ID: 36535542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-bound versus soluble major histocompatibility complex Class I-related chain A and major histocompatibility complex Class I-related chain B differential expression: Mechanisms of tumor eradication versus evasion and current drug development strategies.
    Suresh PK
    J Cancer Res Ther; 2016; 12(4):1224-1233. PubMed ID: 28169232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model.
    Liu Y; Li Y; Liu S; Adeegbe DO; Christensen CL; Quinn MM; Dries R; Han S; Buczkowski K; Wang X; Chen T; Gao P; Zhang H; Li F; Hammerman PS; Bradner JE; Quayle SN; Wong KK
    Cancer Res; 2018 Jul; 78(13):3709-3717. PubMed ID: 29760044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells.
    Ferrari de Andrade L; Kumar S; Luoma AM; Ito Y; Alves da Silva PH; Pan D; Pyrdol JW; Yoon CH; Wucherpfennig KW
    Cancer Immunol Res; 2020 Jun; 8(6):769-780. PubMed ID: 32209637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.
    Song DG; Ye Q; Santoro S; Fang C; Best A; Powell DJ
    Hum Gene Ther; 2013 Mar; 24(3):295-305. PubMed ID: 23297870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles of Natural Killer Group 2D Ligands (NGK2DLs) in colorectal carcinoma and changes in response to chemotherapeutic agents.
    Kucuk B; Yilmaz E; Cacan E
    Mol Biol Rep; 2021 May; 48(5):3999-4008. PubMed ID: 34009568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
    Zhang C; Röder J; Scherer A; Bodden M; Pfeifer Serrahima J; Bhatti A; Waldmann A; Müller N; Oberoi P; Wels WS
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer.
    Cai L; Liu H; Huang F; Fujimoto J; Girard L; Chen J; Li Y; Zhang YA; Deb D; Stastny V; Pozo K; Kuo CS; Jia G; Yang C; Zou W; Alomar A; Huffman K; Papari-Zareei M; Yang L; Drapkin B; Akbay EA; Shames DS; Wistuba II; Wang T; Johnson JE; Xiao G; DeBerardinis RJ; Minna JD; Xie Y; Gazdar AF
    Commun Biol; 2021 Mar; 4(1):314. PubMed ID: 33750914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA.
    Kim Y; Born C; Bléry M; Steinle A
    Front Immunol; 2020; 11():960. PubMed ID: 32582150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.